Sutton Wealth Advisors Inc. - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 147 filers reported holding CONMED CORP in Q4 2016. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sutton Wealth Advisors Inc. ownership history of CONMED CORP
ValueSharesWeighting
Q4 2022$48,752
+38.8%
550
+25.6%
0.02%
+35.7%
Q3 2022$35,114
-43.4%
438
-32.4%
0.01%
-44.0%
Q2 2022$62,052
-13.7%
648
+33.9%
0.02%0.0%
Q1 2022$71,898
+16.3%
484
+11.0%
0.02%
+19.0%
Q4 2021$61,807
+10.1%
436
+1.6%
0.02%0.0%
Q3 2021$56,126
-4.8%
4290.0%0.02%
-4.5%
Q2 2021$58,957
+5.2%
4290.0%0.02%0.0%
Q1 2021$56,023
+16.6%
4290.0%0.02%
+10.0%
Q4 2020$48,048
+42.4%
4290.0%0.02%
+25.0%
Q3 2020$33,749
+9.3%
4290.0%0.02%0.0%
Q2 2020$30,884
+30.3%
429
+3.6%
0.02%
+6.7%
Q1 2020$23,710
-33.1%
414
+30.6%
0.02%
-16.7%
Q4 2019$35,450
+25.8%
317
+8.2%
0.02%
+12.5%
Q3 2019$28,172
+12.4%
2930.0%0.02%
+14.3%
Q2 2019$25,072
+2.9%
2930.0%0.01%0.0%
Q1 2019$24,372
+29.6%
2930.0%0.01%
+16.7%
Q4 2018$18,811
-19.0%
2930.0%0.01%
-20.0%
Q3 2018$23,211
+8.2%
2930.0%0.02%0.0%
Q2 2018$21,448
+15.6%
2930.0%0.02%
+15.4%
Q1 2018$18,556
+24.3%
2930.0%0.01%
+18.2%
Q4 2017$14,934
-2.9%
2930.0%0.01%
-8.3%
Q3 2017$15,374
-7.3%
293
-29.2%
0.01%
-20.0%
Q3 2016$16,585
-20.5%
414
-5.3%
0.02%
-25.0%
Q2 2016$20,858
+13.8%
4370.0%0.02%
+17.6%
Q1 2016$18,3284370.02%
Other shareholders
CONMED CORP shareholders Q4 2016
NameSharesValueWeighting ↓
HealthCor Management, L.P. 27,500$2,437,6002.23%
Ranger Investment Management 316,318$28,038,4282.08%
Lighthouse Investment Partners, LLC 142,100$12,595,7441.39%
Lighthouse Investment Partners, LLC 139,200$12,338,6881.36%
EARNEST PARTNERS LLC 2,402,352$212,944,4811.30%
Lighthouse Investment Partners, LLC 108,200$9,590,8481.06%
MOODY ALDRICH PARTNERS LLC 51,885$4,599,0860.93%
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID 125,435$11,118,5580.81%
Champlain Investment Partners, LLC 1,275,910$113,096,6620.72%
EPIQ PARTNERS, LLC 10,463$927,4400.62%
View complete list of CONMED CORP shareholders